Xuantai Pharmaceutical (688247.SH): Isaconazole sulfate for injection was approved by the State Drug Administration

Zhitong Finance App News, Xuantai Pharmaceutical (688247.SH) issued an announcement. Recently, the company received the “Drug Registration Certificate” approved and issued by the State Drug Administration (“State Drug Administration”) to approve the marketing of the company's injectable isaconazole sulfate. Injectable isaconazole sulfate is suitable for the treatment of the following infections in adult patients: aggressive aspergillosis, invasive trichoblastosis.